Skip to main content
BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.40
-0.15 (-0.73%)
Nov 13, 2026, 1:30 PM CST

BioGend Therapeutics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,7404,7754,1814,7082,2472,757
Market Cap Growth
-43.28%14.21%-11.18%109.50%-18.50%-22.86%
Enterprise Value
1,9304,2693,5583,9901,7202,063
Last Close Price
20.4038.2833.5538.1321.7326.32

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.6521.4824.9442.8371.46297.47
PB Ratio
2.626.304.944.923.072.92
P/TBV Ratio
2.947.336.096.094.734.53

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.2119.2021.2236.3054.70222.54

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.010.010.020.01
Net Debt / Equity Ratio
-0.77-0.67-0.72-0.74-0.65-0.73
Net Debt / EBITDA Ratio
13.437.948.155.682.804.97
Net Debt / FCF Ratio
13.147.806.124.322.564.98
Asset Turnover
0.240.260.170.120.030.01
Inventory Turnover
2.673.412.291.891.240.64
Quick Ratio
10.5916.8421.0616.9016.7328.58
Current Ratio
11.3017.6021.6017.3217.0129.24
Return on Equity (ROE)
-9.91%-11.88%-13.30%-19.07%-24.54%-17.51%
Return on Assets (ROA)
-6.80%-7.99%-7.78%-11.79%-14.85%-11.74%
Return on Capital Employed (ROCE)
-10.10%-14.20%-13.90%-17.60%-27.70%-16.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.23%-1.77%-2.79%-3.32%-8.21%-5.02%
FCF Yield
-2.28%-1.37%-2.38%-3.50%-8.32%-4.99%
Buyback Yield / Dilution
-2.97%--2.32%-16.69%-1.77%-15.90%